Oil giant BP ousts new chairman over ‘conduct’ and shares slide

BP ousted its chairman Albert Manifold over serious governance, oversight and conduct concerns, triggering a 5% slide in the shares. The company also reported 2025 earnings down 16% to $7.49 billion as Brent crude prices fell 16.9%, underscoring weaker operating conditions. The board has appointed Ian Tyler as interim chair and begun a search for a permanent replacement.

Analysis

This is less a one-off governance stumble than a sign the board is still fighting the same strategic identity crisis that has haunted the equity for years. A chair ouster this abrupt typically raises the cost of capital at the margin because investors start demanding a governance discount for strategic reversals, and that discount tends to persist for quarters, not days, until the board proves it can execute without another reset. The immediate share reaction looks like a knee-jerk de-risking, but the bigger issue is that BP is now effectively in a longer chair-search window while also needing to maintain credibility with both value and ESG-oriented holders.

Second-order winners are more likely to be the cleaner governance and simpler-capital-allocation peers than the obvious headline rival. Capital that was willing to tolerate BP’s transition ambiguity can rotate toward Shell or US majors if BP’s board instability keeps distracting management from buybacks, portfolio pruning, and upstream discipline. The problem for BP is not just reputation: if investors start believing the board cannot hold the line on strategy, they will apply a lower multiple to every future project approval, especially long-dated energy-transition bets with weak visibility.

Near term, the key catalyst is whether the company uses the leadership vacuum to reassure investors with a sharper capital return framework rather than another strategic review. Over the next 1-3 months, any sign the new chair search drags or becomes politicized could pressure the shares further, while a credible external candidate with a strong governance reputation would likely trigger a relief rally. The contrarian view is that the market may be overpricing chaos here: if the core cash-generating asset base is intact and the board quickly installs a steady hand, this could become a buying opportunity on multiple compression rather than an earnings problem.

Key Decisions for Investors

• Short BP common on any bounce over the next 2-6 weeks; risk/reward favors fading relief rallies until a permanent chair is named and capital allocation guidance is reaffirmed.
• Pair trade: long SHEL / short BP for 1-3 months. Thesis: Shell should absorb the governance premium BP just forfeited, with lower execution risk and better investor trust.
• Buy BP put spreads 2-4 months out to express downside while limiting premium bleed. Best if chair-search uncertainty persists and analyst multiple compression extends beyond the initial headline reaction.
• If managing a broader European energy basket, overweight integrated peers vs BP for the next quarter; expect BP to lag on both sentiment and multiple until governance is stabilized.
• Contrarian entry: only consider buying BP after a credible external chair is announced and the stock retests post-selloff lows without further governance headlines; then the setup improves for a 6-12 month mean reversion trade.